Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells

• Published in: Journal of experimental & clinical cancer research 2021-01, Vol.40 (1), p.20-17, Article 20
• Main Authors: Chen, Zihang, Wang, Huizhi, Zhang, Zongpu, Xu, Jianye, Qi, Yanhua, Xue, Hao, Gao, Zijie, Zhao, Rongrong, Wang, Shaobo, Zhang, Shouji, Qiu, Wei, Guo, Xing, Li, Gang
• Format: Article
• Language: English
• Subjects: Amyloid Precursor Protein Secretases - genetics; Amyloid Precursor Protein Secretases - metabolism; Analysis; Animals; Antibodies; Apoptosis; Aspartic Acid Endopeptidases - genetics; Aspartic Acid Endopeptidases - metabolism; BACE2; Brain Neoplasms - genetics; Brain Neoplasms - metabolism; Brain Neoplasms - pathology; Cancer; Cell cycle; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Gene expression; Genetic aspects; Genomes; Genomics; Glioblastoma - genetics; Glioblastoma - metabolism; Glioblastoma - pathology; Glioma; Glioma stem cell; Gliomas; GRP78; Health aspects; Heat-Shock Proteins - metabolism; Heterografts; Humans; Lysosomes - metabolism; Lysosomes - pathology; Male; Mass spectrometry; Mesenchymal Stem Cells - metabolism; Mesenchymal Stem Cells - pathology; Mesenchymal subtype; Mice; Mice, Nude; Neoplastic Stem Cells - metabolism; Neoplastic Stem Cells - pathology; Phenotype; Proteins; Radiation; Stem cells; Viral antibodies
• ISSN: 1756-9966; 0392-9078; 1756-9966
• DOI: 10.1186/s13046-020-01807-4

Glioma stem cells (GSCs) are considered the initial cells of gliomas, contributing to therapeutic resistance. Patient-derived GSCs well recapitulate the heterogeneity of their parent glioma tissues, which can be classified into different subtypes. Likewise, previous works identified GSCs as two distinct subtypes, mesenchymal (MES) and proneural (PN) subtypes, and with general recognition, the MES subtype is considered a more malignant phenotype characterized by high invasion and radioresistance. Therefore, understanding the mechanisms involved in the MES phenotype is necessary for glioblastoma treatment. Data for bioinformatic analysis were obtained from The Cancer Genome Atlas (TCGA) and The Gene Expression Omnibus (GEO) database. An antibody was used to block cell surface glucose-regulated protein 78 (csGRP78). Apoptosis and cell cycle analyses were performed to evaluate radiation damage. Immunofluorescence staining was applied to assess protein expression and distribution. Mass spectrometry combined with bioinformatic analysis was used to screen downstream molecules. Intracranial GSC-derived xenografts were established for in vivo experiments. Total GRP78 expression was associated with MES GSC stemness, and csGRP78 was highly expressed in MES GSCs. Targeting csGRP78 suppressed the self-renewal and radioresistance of MES GSCs in vitro and in vivo, accompanied by downregulation of the STAT3, NF-κB and C/EBPβ pathways. Mass spectrometry revealed the potential downstream β-site APP-cleaving enzyme 2 (BACE2), which was regulated by csGRP78 via lysosomal degradation. Knockdown of BACE2 inactivated NF-κB and C/EBPβ and significantly suppressed the tumorigenesis and radioresistance of MES GSCs in vitro and in vivo. Cell surface GRP78 was preferentially expressed in MES GSCs and played a pivotal role in MES phenotype maintenance. Thus, blocking csGRP78 in MES GSCs with a high-specificity antibody might be a promising novel therapeutic strategy.